Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CEPI NASDAQ:FMED NYSEARCA:PPEM NYSEARCA:SAGP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCEPIREX Crypto Equity Premium Income ETF$41.77-0.1%$39.73$31.35▼$52.16$53.88MN/A25,179 shs31,839 shsFMEDFidelity Disruptive Medicine ETF$23.57-1.4%$23.65$20.69▼$26.79$51.87M1.015,547 shs6,043 shsPPEMPutnam PanAgora ESG Emerging Markets Equity ETF$25.04-0.1%$23.97$18.92▼$25.08$53.21M1.074,665 shs1,695 shsSAGPStrategas Global Policy Opportunities ETF$33.03-0.2%$32.15$26.99▼$33.25$53.84M0.823,672 shs1,118 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCEPIREX Crypto Equity Premium Income ETF0.00%+2.73%+5.75%+18.23%+4,176,999,900.00%FMEDFidelity Disruptive Medicine ETF0.00%-1.07%+0.90%+4.74%-6.04%PPEMPutnam PanAgora ESG Emerging Markets Equity ETF0.00%+1.66%+4.51%+20.62%+13.41%SAGPStrategas Global Policy Opportunities ETF0.00%+0.58%+3.38%+12.39%+16.38%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCEPIREX Crypto Equity Premium Income ETFN/AN/AN/AN/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/AN/AN/AN/AN/AN/AN/APPEMPutnam PanAgora ESG Emerging Markets Equity ETFN/AN/AN/AN/AN/AN/AN/AN/ASAGPStrategas Global Policy Opportunities ETFN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCEPIREX Crypto Equity Premium Income ETF 2.77Moderate Buy$41.77N/AFMEDFidelity Disruptive Medicine ETF 2.84Moderate Buy$23.57N/APPEMPutnam PanAgora ESG Emerging Markets Equity ETF 2.78Moderate Buy$25.04N/ASAGPStrategas Global Policy Opportunities ETF 2.44Hold$33.03N/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCEPIREX Crypto Equity Premium Income ETFN/AN/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/AN/AN/AN/AN/APPEMPutnam PanAgora ESG Emerging Markets Equity ETFN/AN/AN/AN/AN/AN/ASAGPStrategas Global Policy Opportunities ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCEPIREX Crypto Equity Premium Income ETFN/AN/A33.99∞N/AN/AN/AN/AN/AFMEDFidelity Disruptive Medicine ETFN/AN/A41.33∞N/AN/AN/AN/AN/APPEMPutnam PanAgora ESG Emerging Markets Equity ETFN/AN/A15.43∞N/AN/AN/AN/AN/ASAGPStrategas Global Policy Opportunities ETFN/AN/A20.47∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCEPIREX Crypto Equity Premium Income ETF$8.8321.14%N/AN/AN/AFMEDFidelity Disruptive Medicine ETF$0.110.47%N/AN/AN/APPEMPutnam PanAgora ESG Emerging Markets Equity ETF$0.682.72%N/AN/AN/ASAGPStrategas Global Policy Opportunities ETF$0.631.91%N/AN/AN/ALatest PPEM, FMED, CEPI, and SAGP DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/23/2025CEPIREX Crypto Equity Premium Income ETFMonthly$1.379742.13%6/24/20256/24/20256/25/20255/28/2025CEPIREX Crypto Equity Premium Income ETFMonthly$1.388144.09%5/29/20255/29/20255/30/20254/28/2025CEPIREX Crypto Equity Premium Income ETFMonthly$1.328643.23%4/29/20254/29/20254/30/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCEPIREX Crypto Equity Premium Income ETFN/AFMEDFidelity Disruptive Medicine ETFN/APPEMPutnam PanAgora ESG Emerging Markets Equity ETFN/ASAGPStrategas Global Policy Opportunities ETFN/AInsider OwnershipCompanyInsider OwnershipCEPIREX Crypto Equity Premium Income ETFN/AFMEDFidelity Disruptive Medicine ETFN/APPEMPutnam PanAgora ESG Emerging Markets Equity ETFN/ASAGPStrategas Global Policy Opportunities ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCEPIREX Crypto Equity Premium Income ETFN/A1.29 millionN/AN/AFMEDFidelity Disruptive Medicine ETFN/A2.20 millionN/ANot OptionablePPEMPutnam PanAgora ESG Emerging Markets Equity ETFN/A2.13 millionN/ANot OptionableSAGPStrategas Global Policy Opportunities ETFN/A1.63 millionN/ANot OptionablePPEM, FMED, CEPI, and SAGP HeadlinesRecent News About These CompaniesStrategas Launches Two New Thematic Exchange Traded FundsJanuary 31, 2022 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePPEM, FMED, CEPI, and SAGP Company DescriptionsREX Crypto Equity Premium Income ETF NASDAQ:CEPI$41.77 -0.03 (-0.07%) As of 07/18/2025 03:34 PM EasternThe REX Crypto Equity Premium Income ETF (CEPI) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is actively managed, investing in crypto-related and digital payment solutions stocks selected from the index. The fund seeks to generate income by writing covered call options on its holdings, aiming for capital growth and current income, while maintaining the flexibility to adapt based on market conditions. CEPI was launched on Dec 4, 2024 and is issued by REX Shares.Fidelity Disruptive Medicine ETF NASDAQ:FMED$23.56 -0.34 (-1.40%) Closing price 07/18/2025 03:58 PM EasternExtended Trading$23.56 0.00 (0.00%) As of 07/18/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.Putnam PanAgora ESG Emerging Markets Equity ETF NYSEARCA:PPEM$25.04 -0.02 (-0.08%) Closing price 07/18/2025 04:10 PM EasternExtended Trading$25.05 +0.01 (+0.04%) As of 07/18/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The PortfolioPlus Emerging Markets ETF (PPEM) is an exchange-traded fund that mostly invests in total market equity. The fund actively invests in companies of any capitalization located in emerging markets. Selected companies are perceived to possess positive environmental, social, and governance criteria. PPEM was launched on Jan 19, 2023 and is managed by Putnam.Strategas Global Policy Opportunities ETF NYSEARCA:SAGP$33.03 -0.07 (-0.21%) As of 07/18/2025 04:10 PM EasternThe Strategas Global Policy Opportunities ETF (SAGP) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund that invests in various global stocks engaged in lobbying activities with the US federal government. SAGP was launched on Jan 24, 2022 and is managed by Strategas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
